Symbol
Celldex Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$19.78
Current price of the stock
$924K
Trading volume of the stock
$1.3B
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.73
Mean analyst rating
201.39%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
24.27
Current ratio
100.00%
Gross profit margin
-1633.53%
Operating profit margin
-1633.53%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1319.99%
Pretax profit margin
-1319.99%
Net profit margin
-5.36%
Measures profitability relative to shareholders' equity
-5.55%
ROE excluding intangible assets
-5.12%
Measures profitability relative to total assets
-5.36%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
3.75
Receivables turnover ratio
24.03
Average number of days it takes to collect receivables
-7.67
Measures valuation relative to earnings
-
P/E based on future earnings estimates
131.45
Measures valuation relative to sales
1.67
Measures valuation relative to book value
-3.38
Measures valuation relative to operating cash flow
-3.34
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
